Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 95, Issue 8, 2011, Pages

  Spitzer, Dietmar ^a   Wogatzky, Johannes ^b   Murtinger, Maximilian ^b   Zech, Mathias H ^b   Haidbauer, Robert ^a   Zech, Nicolas H ^b,c  

^a IVF Centers Prof Zech   (Austria)

^b IVF Centers Prof Zech   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

bromocriptine; Dopamine agonists; ovarian hyperstimulation syndrome; prevention

Indexed keywords

BROMOCRIPTINE MESILATE; DALTEPARIN; DOPAMINE RECEPTOR STIMULATING AGENT; ENOXAPARIN; ESTRADIOL VALERATE; PROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HEPARINIZATION; HOSPITAL ADMISSION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; NAUSEA; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TESTICULAR SPERM ASPIRATION; TESTICULAR SPERM EXTRACTION; VOMITING;

EID: 79959738632     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.02.032     Document Type: Article

References (16)

1. B. Rizk, M. Aboulghar, J. Smitz, and R. Ron-El The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome Hum Reprod Update 3 1997 255 266 (Pubitemid 27437930)
2. C. Busso Symposium: update on prediction and management of OHSS. Prevention of OHSS- dopamine agonists RBM Online 19 2009 43 51
3. R. Gomez, M. Gonzalez, C. Simon, J. Remohi, and A. Pellicer Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS Fertil Steril 80 Suppl 3 2003 S43 S44
4. J. Garcia-Velasco How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists RBM Online 19 2009 71 75
5. S. Soares, R. Gomez, C. Simon, J. Garcia-Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum Reprod Update 14 2008 321 333 (Pubitemid 351858972)
6. P. Humaidan, J. Quartarolo, and G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 2010 389 400
7. C. Carizza, V. Abdelmassih, S. Abdelmassih, P. Ravizzini, L. Salgueiro, and T.P. Salgueiro Cabergoline reduces the early onset of ovarian hyperstimulaton syndrome: a prospective randomized study RBM Online 17 2008 751 755
8. M. Youssef, M. van Wely, M.A. Hassan, H.G. Al-Inany, M. Mochtar, and S. Khattab Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis Hum Reprod Update 16 2010 459 466
9. C. Busso, M. Fernandez-Sanchez, J. Garcia-Velasco, J. Landeras, A. Ballesteros, and E. Munoz Quinagolide is effective in preventing moderate/severe early OHSS in IVF patients: a randomised, double-blind, placebo-controlled trial Hum Reprod 23 Suppl 2008 i60
10. C. Busso, M. Fernandez-Sanchez, J. Garcia-Velasco, J. Landeras, A. Ballesteros, and E. Muñoz The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial Hum Reprod 25 2010 995 1004
11. C.A. Lyons, C.A. Wheeler, G.N. Frishman, R.J. Hackett, D.B. Seifer, and R.V. Haning Jr. Early and late presentation of the ovarian hyperstimulation syndrome. Two distinct entities with different risk factors Hum Reprod 9 1994 792 799 (Pubitemid 24168060)
12. P. Crosignani Current treatment issues in female hyperprolactinaemia Eur J Obstet Gynecol Reprod Biol 125 2006 152 164
13. C. Weil The safety of bromocriptine in hyperprolactinaemic female infertility. A literature review Curr Med Res Opin 10 1986 172 195 (Pubitemid 16095805)
14. P. Kovács, S. Mátyás, and S.G. Kaali Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders Fertil Steril 5 2006 913 917
15. P. Humaidan, J. Quartarolo, and E.G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 2010 389 400
16. C.A. Venetis, E.M. Kolibianakis, K.A. Toulis, D.G. Goulis, I. Papadimas, and B.C. Tarlatzis Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis Fertil Steril 95 2011 188 196